Psychotropic drug use in older developmentally disabled with behavioral difficulties.

The team mailed a survey to every large residential home in one English county. They asked about every resident over 40 who had intellectual disability. For each person they noted age, setting size, behavior problems, and current psychotropic drugs.

In total they got data on the adults. The goal was to see if older age or tougher behavior predicted who received tranquilizers, antidepressants, or antipsychotics.

Older residents were medicated more often. Sixty-five-year-olds were twice as likely to be on psychotropics as forty-year-olds.

Larger congregate homes also used more drugs than small group homes. Yet the records showed no link between drug use and actual aggression, self-injury, or other target behaviors. In short, setting and age drove prescribing, not behavior.

Bauman et al. (1996) followed the same age group for six years and saw daily-living skills drop sharply after age 60. Together the two studies sketch a pattern: as people with ID age, they lose skills and gain pills, but the pills do not match measured behavior.

Griffith et al. (2012) added that most adults over 50 with ID have the fitness level of someone 20 years older. Thus ageing in ID brings low fitness, more meds, and declining skills—a triple hit.

Field et al. (2001) surveyed younger London adults with challenging behavior and found most lived in the community, not large facilities. That contrast explains why C et al. saw high drug rates: big institutions, not client behavior, were the common thread.

If you serve older adults with ID, audit the setting before you accept “he needs this for behavior.” Ask for baseline data. Try non-drug plans first. Push for smaller homes or more active programming. Your review could cut unnecessary sedation and side-effect falls.